Cardiomyopathy/Myocarditis
RSSArticles
-
Troponin and Exercise Testing
-
Treatment of Hypertension: Does Choice of Drug Therapy Make a Difference?
-
Prevention of Postoperative Atrial Fibrillation
-
Predictive Value of Coronary Pressure Measurements After Stenting
-
Reliability of Doppler Echo for Valvular Regurgitation
-
Sudden Death After Radiofrequency Ablation of the Atrioventricular Node
-
Hot Plaques in Acute Coronary Syndromes?
-
Can Beta-Blockers Prevent Anthracycline-Induced Cardiomyopathy?
Anthracyclines may produce cardiotoxicity by apoptosis and free radical formation. Carvedilol, in addition to being a nonselective beta-blocker and alpha 1 blocker, is antioxidant and antiapoptotic. -
Biomarkers, Better Than Conventional Risk Factors?
In recent years there has been considerable interest in the utilization of biomarkers to assist in the prediction of risk for cardiovascular events, including mortality. -
Can Chemotherapy Cardiotoxicity Be Prevented?
The cardiotoxicity of anthracyclines and other agents may negatively affect clinical outcomes in cancer survivors. Data in other clinical situations and animal data on anthracycline-induced cardiomyopathy suggests that angiotensin-converting enzyme inhibitors (ACEI) may ameliorate this cardiotoxicity.